Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Trial Comparing the Effectiveness of Dexmedetomidine Versus Sufentanil on Cerebral Oxygen Saturation in Patients With Traumatic Brain Injury (DESTIN Trial)
Conditions
Interventions
Dexmedetomidine
Sufentanil
Locations
1
Indonesia
RSUD Prof. Margono Soekarjo
Purwokerto, Central Java, Indonesia
Start Date
June 1, 2025
Primary Completion Date
July 31, 2025
Completion Date
August 31, 2025
Last Updated
November 28, 2025
NCT04521881
NCT07455136
NCT06725108
NCT06734026
NCT07357090
NCT06467708
Lead Sponsor
Universitas Jenderal Soedirman
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions